4//SEC Filing
Stauderman Kenneth A. 4
Accession 0001415889-25-018308
CIK 0001534133other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 6:29 PM ET
Size
6.0 KB
Accession
0001415889-25-018308
Insider Transaction Report
Form 4
Stauderman Kenneth A.
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2025-06-24+47,125→ 47,125 totalExercise: $1.53Exp: 2035-04-22→ Common Stock (47,125 underlying)
Footnotes (2)
- [F1]The option grant was approved by the Board of Directors of CalciMedica, Inc. (the "Company") on April 23, 2025, subject to stockholder approval of an amendment of the Company's 2023 Equity Incentive Plan (the "Amended 2023 EIP") under which the option was granted. The Company's stockholders approved the Amended 2023 EIP on June 24, 2025.
- [F2]Immediately exercisable.
Documents
Issuer
CalciMedica, Inc.
CIK 0001534133
Entity typeother
Related Parties
1- filerCIK 0001969388
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 6:29 PM ET
- Size
- 6.0 KB